SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BNB is the native utility token of the BNB Chain ecosystem, acting as a multi-chain asset that powers decentralized applications and facilitates value exchange across its network. It serves as the primary asset for paying transaction gas and smart contract deployment fees while providing users with tiered fee discounts on the Binance exchange. The project’s main value proposition lies in its unified multi-chain architecture, which integrates a smart contract platform, a Layer 2 scaling solution, and a decentralized data storage network into a cohesive settlement and data availability layer.  The network operates on a Proof of Staked Authority consensus mechanism, utilizing a group of 21 active validators known as the Cabinet to verify transactions and produce blocks every 3 seconds. Validators are elected daily based on the amount of BNB staked or delegated to them, and the system employs fast finality and slashing penalties to maintain security and integrity. To manage its long-term economy, the project uses a programmatic dual-burn strategy that permanently removes tokens through real-time fee destruction and quarterly buybacks.  Launched in 2017 by the Binance platform, the project initially distributed 50% of its 200 million token supply to the public, while the founding team received 40% and angel investors were allocated 10%. Though it began as a token on the Ethereum network, it eventually migrated to its own autonomous architecture that remains fully compatible with the Ethereum Virtual Machine. Today, the token's utility includes paying for network gas, participating in staking rewards, and enabling decentralized governance through which holders can vote on technical upgrades and economic changes.

Binance

BNBs rebound and choppy consolidation are driving mostly technical trading discussion, with repeated chart posts describing a neutral range. Traders are split between expecting more upside after support held and warning that the bounce may be a bull trap or corrective move; no single fundamental catalyst is established.

Bank of Montreal engages in the provision of banking and financial services to individuals and institutions. It operates through the following segments: Canadian Personal and Commercial Banking (Canadian P&C), United States Personal and Commercial Banking (U.S. P&C), BMO Wealth Management, BMO Capital Markets, and Corporate Services. The company was founded by Robert Armour, John C. Bush, Austin Cuvillier, George Garden, Horatio Gates, James Leslie, George Moffatt, John Richardson and Thomas A. Turner on June 23, 1817 and is headquartered in Montreal, Canada.

Bank of Montreal - MicroSectors Gold Miners 3X Leveraged ETN

Sharp, volatile swings in gold miners are driving discussion, with traders linking recent weakness to rising Treasury yields, a stronger dollar, oil costs, and Fed-rate concerns; the ETNs 3x leverage magnifies the moves. The community is split between expecting further downside and treating pullbacks as buying opportunities based on a longer-term bullish view of gold.

Whirlpool Corp. engages in the manufacturing and marketing of home appliances. Its products include home laundry appliances, refrigerators and freezers, cooking appliances, home dishwashers, and room air-conditioning equipment, mixers, and portable household appliances. The firm's brands include Whirlpool, KitchenAid, Maytag, Consul, Brastemp, Amana, Bauknecht, JennAir, and Indesit. It operates through the following geographical segments: Major Domestic Appliances (MDA) North America, Major Domestic Appliances (MDA) Latin America, Small Domestic Appliances (SDA) Global, and Others. The company was founded by Emory Upton, Fred Upton, and Louis C. Upton on November 11, 1911 and is headquartered in Benton Harbor, MI.

Whirlpool Corp.

Whirlpools weak quarterly results, reduced outlook, and dividend suspension have intensified concern over recession-level appliance demand, debt, and liquidity; management attributed the demand slump partly to the Iran war. Traders are divided between fears of further financial distress and contrarian bets on an oversold rebound, with many blaming management and disputing the companys explanation.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

AstraZenecas strategic investment in Summit and clinical collaboration on ivonescimab combinations are driving attention, with many traders viewing the deal as validation of the cancer drug and relief for Summits funding needs. Others caution that the equity investment is dilutive and not a buyout, while the separate FDA decision on ivonescimab remains uncertain.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is drawing attention after early Phase 1 azer-cel data in progressive MS showed disability scores stable or improved in most evaluable patients, with no major high-grade safety signals reported. Traders view the results as a promising pipeline addition to BRIUMVI, while noting the small, early-stage study and debating the muted share-price reaction; earnings and subcutaneous BRIUMVI data remain key points of focus.

The Ondo Foundation was founded in 2022 as an independently governed and nonprofit Cayman Islands Foundation Company with no beneficial owners. The Ondo Foundation assisted in the launch of the Ondo DAO, which deployed and currently governs Flux Finance, the first lending protocol supporting tokenized securities as collateral.  ONDO token holders are entrusted with shaping the future of the Ondo DAO so that it continues to pursue its mission to democratize access to institutional-grade finance. The Ondo DAO gives ONDO holders specific rights pertaining to Flux Finance, which is currently governed by the Ondo DAO.

Ondo

Renewed attention centers on Ondos role in real-world-asset tokenization and reported institutional integrations, which bulls see as a long-term growth driver. Traders disagree on whether that business momentum can lift ONDO itself, citing uncertainty over a fee switch and token-holder value accrual, as well as dilution concerns and the tokens sensitivity to Bitcoin and broader crypto moves.

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

Astrazeneca plc

AstraZeneca PLC

Positive Phase 3 small-cell lung cancer results for Amgens IMDELLTRA combined with AstraZenecas IMFINZI are drawing attention, with traders highlighting the survival benefit as support for AZNs oncology growth story. The discussion also points to recent cancer-drug developments, though reactions to the stocks performance remain mixed.

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.

Agenus Inc

Agenuss NEST Phase 2 results for neoadjuvant BOT+BAL in colorectal cancer are drawing attention, with reports of substantial tumor responses, ctDNA clearance, and no observed recurrences during follow-up. Bullish traders view the findings as evidence of promise, while skeptics emphasize the small, nonrandomized study and ongoing concerns about execution and dilution.

Bonk is a dog-themed memecoin on the Solana blockchain, launched on Christmas Day 2022 to revitalize the Solana community following the FTX collapse. Created by an anonymous team of 22 Solana developers and builders, Bonk distributed 50% of its total 100 trillion token supply via airdrop to community members including NFT collectors, developers, and artists.   The project positions itself as "the first Solana dog coin for the people, by the people," explicitly rejecting venture capital backing in favor of grassroots community ownership. What sets Bonk apart from other memecoins is its combination of fair launch mechanics, extensive ecosystem integration, and active deflationary strategy.   Built on Solana, BONK benefits from fast transaction speeds and low fees that make it practical for everyday use. Native products include LetsBonk.fun (a memecoin launchpad that briefly became Solana's market leader in 2025, surpassing Pump.fun with over 78% market share), BonkSwap (a decentralized exchange) and BonkBot (a Telegram trading bot with built-in burn mechanics).   BONK is available across 10 blockchain networks and listed on major exchanges including Binance, Coinbase, Kraken, and Robinhood. Governance is handled by BonkDAO, which holds 15% of the token supply and makes decisions through on-chain voting.   The community has organized several major burn events, most notably the December 2024 BURNmas campaign that destroyed 1.69 trillion tokens worth over $50 million. In September 2025, Nasdaq-listed Safety Shot, Inc. formed BONK Holdings LLC and acquired over 2.5% of the circulating supply (valued at $55-63 million), making BONK one of the first memecoins to attract formal corporate treasury adoption. Core contributor Nom was appointed to Safety Shot's board, and the company holds a 10% revenue share in LetsBonk.fun.  As with all memecoins, BONK is a highly speculative asset with substantial volatility. Its value is primarily driven by community sentiment, social media momentum, and meme culture rather than traditional utility.   The anonymous team, while common in the memecoin space, means investors should exercise appropriate caution. Despite these risks, Bonk has established itself as one of the most successful community-driven tokens in the Solana ecosystem, approaching 1 million unique holders and expanding from a simple memecoin into meaningful DeFi infrastructure.

BONK

The discussion centers on hopes for a BONK and broader memecoin rebound, with traders pointing to growing holder counts and an anticipated BonkFun relaunch as possible tailwinds. Optimism is tempered by frustration over weak, volatile price action, and the relaunch remains speculative.

Vanguard Index Funds - Vanguard Morningstar Total Stock Market ETF

Vanguard Total Stock Market ETF

VTI is being discussed as a proxy for the broad U.S. market, with traders divided on its outlook: bearish voices cite inflation, rising rates, oil and AI-sector valuation risks, while others favor dip-buying, technical support setups and long-term index investing.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is Schwab Fundamental International Small Company Index ETF (FNDC) a Strong ETF Right Now?

Curaleaf's Q4 Profit Swing Ignites Retail Chatter, But Shrinking Revenue Dampens The High

Equity

Chairman and CEO Boris Jordan pointed to the company's strengthened cash position, with $107 million in cash at year-end, and operating and free cash flow of $163 million and $70 million.


Schwab Strategic Trust - Schwab Fundamental International Small Equity ETF

Neutral Sentiment

Shares of cannabis retailer Curaleaf Holdings dropped nearly 10% on Monday after the company posted mixed fourth-quarter earnings.&nbsp;While Curaleaf reported a profit of $12.4 million, or $0.02 per share, compared with a $5 million loss from the same period last year, revenue declined to $331.1 million from $345.3 million.Chairman and CEO Boris Jordan highlighted the company's profitability metrics, noting that Curaleaf achieved an adjusted gross margin of 48% and an adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) of $76 million.&nbsp;He also pointed to the company's strengthened cash position, with $107 million in cash at year-end, and operating and free cash flow of $163 million and $70 million, respectively."Over the past two quarters, my primary objective has been to amplify our strengths, address key challenges, and stabilize the business," Jordan said."Having successfully achieved this, we are now forging ahead with our 'Return to our ROOTS' initiative—an ambitious strategy centered on driving organic growth, optimizing margins and cash flow, and reducing debt."Message volume for Curaleaf surged 366% on Stocktwits following the earnings release, with posts reflecting a divide between bullish and bearish sentiment.&nbsp;One trader emphasized Curaleaf's dominant position in the industry, its $1.34 billion annual sales, and improving cash flow, arguing that the company remains well-positioned despite foreign exchange headwinds affecting international sales.&nbsp;<stembedurl>https://stocktwits.com/angelfromsky/message/606622013</stembedurl>Others, however, focused on the revenue decline, with one trader calling it a "solid miss as usual" and another predicting that the stock would slip below $1.<stembedurl>https://stocktwits.com/symbol/CURLF/earnings</stembedurl>Curaleaf and its industry peers have been&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.marketwatch.com/story/trulieve-curaleaf-and-green-thumb-launch-hemp-based-thc-drinks-as-cannabis-reforms-stall-2f03d249">expanding</a> into THC-infused beverages as federal cannabis legalization efforts stall.&nbsp;Last week, the company announced a partnership with Total Wine &amp; More to distribute its Select Zero Proof line of hemp-derived THC seltzers.Curaleaf stock has lost over 28% this year.&nbsp;According to Koyfin data, it trades about 240% below the average price target of $4.02 from 10 analysts. Seven rate it a 'buy,' one assigns a 'strong buy,' and two have a 'hold' rating.For updates and corrections, email newsroom[at]stocktwits[dot]com.

A Curaleaf medical cannabis dispensary in Forest Hills, Queens, NY. (Photo by: Lindsey Nicholson/UCG/Universal Images Group via Getty Images)

Chairman and CEO Boris Jordan pointed to the company's strengthened cash position, with $107 million in cash at year-end, and operating and free cash flow of $163 million and $70 million.

Amplify Seymour Cannabis ETF

Curaleaf Holdings Inc

Schwab Strategic Trust - Schwab Fundamental International Small Company Index ETF

Roundhill Cannabis ETF

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Fundamentals

Info

FNDC Schwab Strategic Trust - Schwab Fundamental International Small Company Index ETF

Fundamentals

Latest FNDC News